How effective is Methotrexate for Systemic Lupus Erythematosus? (a real world drug study)
Summary:
Overall ratings: 3.2/5 Long term ratings: 3.3/5
This is a phase IV clinical study of how effective Methotrexate (methotrexate sodium) is for Systemic lupus erythematosus and for what kind of people. The study is created by eHealthMe from 81 Methotrexate users and is updated continuously.
What is Methotrexate?
Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,313 Methotrexate users. Check the latest studies of Methotrexate.
What is Systemic lupus erythematosus?
Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,088 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.
81 people are studied for taking Methotrexate in Systemic lupus erythematosus
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Methotrexate effectiveness for Systemic lupus erythematosus (number of people):
Overall:
- not at all: 1
- somewhat: 19
- moderate: 32
- high: 21
- very high: 8
Long Term:
- not at all: 0
- somewhat: 5
- moderate: 19
- high: 8
- very high: 4
Gender of people who take Methotrexate for Systemic lupus erythematosus *:
- female: 91.36 %
- male: 8.64 %
Age of people who take Methotrexate for Systemic lupus erythematosus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.47 %
- 20-29: 11.11 %
- 30-39: 18.52 %
- 40-49: 32.1 %
- 50-59: 23.46 %
- 60+: 12.35 %
Who find Methotrexate more effective for Systemic Lupus Erythematosus?
Gender of people who take Methotrexate for Systemic lupus erythematosus *:
- female: 89.66 %
- male: 10.34 %
Age of people who take Methotrexate for Systemic lupus erythematosus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 17.24 %
- 30-39: 20.69 %
- 40-49: 34.48 %
- 50-59: 13.79 %
- 60+: 13.79 %
* Approximation only. Some reports may have incomplete information.
Do you take Methotrexate?
- You can start a phase IV clinical trial to monitor Methotrexate safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hania A, "Pyoderma Gangrenosum in a Patient With Systemic Lupus Erythematosus: Case Report", Journal of Medical Cases, 2014 Aug .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Related studies
Alternative drugs to, pros and cons of:
- Methotrexate (604,313 reports)
Treatments, associated drugs and conditions:
- Systemic lupus erythematosus (76,948 reports)
How the study uses the data?
The study is based on methotrexate sodium (the active ingredients of Methotrexate) and Methotrexate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Wellbutrin and Bone Giant Cell Tumour for Women aged 50-59 - 3 seconds ago
- Wellbutrin and Bone Giant Cell Tumor for Women aged 50-59 - 3 seconds ago
- Irritability and drugs of ingredients of atenolol - 5 seconds ago
- Glaucoma and Fungal Nail Infection - 6 seconds ago
- Fludara and Budesonide drug interactions for men aged 40-49 - 9 seconds ago
- Viagra and Lactulose drug interactions for men aged 60+ - 10 seconds ago
- How effective is Invega for Schizoaffective Disorder? - 11 seconds ago
- Could Zoloft cause Body Height Decreased? - 13 seconds ago
- Cervicobrachial Syndrome and drugs of ingredients of azithromycin - 23 seconds ago
- Granisetron Hydrochloride and Sodium Chloride drug interactions for women aged 60+ - 27 seconds ago